Efficacy of Aromatase Inhibition With and Without the Src Inhibitor Saracatinib in Advanced Breast Cancer Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study
Breast Cancer Res Treat 2023 Mar 02;[EPub Ahead of Print], AJ Oswald, SN Symeonides, D Wheatley, S Chan, AM Brunt, K McAdam, P Schmid, S Waters, C Poole, C Twelves, T Perren, J Bartlett, T Piper, EM Chisholm, M Welsh, R Hill, LEM Hopcroft, P Barrett-Lee, DA CameronFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.